慢性肾脏病指南精选.pdfVIP

BMJ 2014;349:g4507 doi: 10.1136/bmj.g4507 (Published 24 July 2014) Page 1 of 6 Practice PRACTICE GUIDELINES Early identification and management of chronic kidney disease in adults: summary of updated NICE guidance 1 1 Serena Carville associate director , David Wonderling head of health economics , Paul Stevens 2 consultant nephrologist , on behalf of the Guideline Development Group 1 2 National Clinical Guideline Centre, Royal College of Physicians, London NW1 4LE, UK; East Kent Hospitals University NHS Foundation Trust, Canterbury CT1 3NG, UK This is one of a series of BMJ summaries of new guidelines based on GFRcreatinine, using creatinine assays with calibration the best available evidence; they highlight important recommendations traceable to standardised reference material for clinical practice, especially where uncertainty or controversy exists. -Use creatinine assays that are specific (for example, The publication of an internationally accepted definition and enzymatic assays) and zero biased compared with isotope classification of chronic kidney disease (CKD) 12 years ago dilution mass spectrometry and precipitated a proliferation of research and literature surrounding -Participate in a UK national external quality assessment the identification of CKD, risk factors for progression